Results 111 to 120 of about 5,262 (161)

Age moderates the relationship between psychedelics use and mental health in naturalistic settings

Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M.   +8 more
europepmc   +1 more source

Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility. [PDF]

Front Neurosci
Evans M, Charrette A.
europepmc   +1 more source

Chaplains in Psychedelic Assisted Therapy: Rationale and Competencies. [PDF]

J Relig Health
Lewis SP, Clark-Soles J, Mayorga O, Sawyer SK, Slavet E, Vidt BJ, Shanti S, Wiggins R, Willis K, Frey J, Grace RM, Cherniak AD.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Psychedelics and Psychotherapy

Pharmacopsychiatry, 2020
AbstractPsychedelics have shown great promise in modern clinical trials for treating various psychiatric conditions. As a transdiagnostic treatment that exerts its effects through subjective experiences that leave enduring effects, it is akin to psychotherapy.
Sandeep, Nayak, Matthew W, Johnson
openaire   +2 more sources

Psychedelics and connectedness

Psychopharmacology, 2017
Psychedelic drugs are creating ripples in psychiatry as evidence accumulates of their therapeutic potential. An important question remains unresolved however: how are psychedelics effective? We propose that a sense of connectedness is key, provide some preliminary evidence to support this, and suggest a roadmap for testing it further.
R L, Carhart-Harris, D, Erritzoe, E, Haijen, M, Kaelen, R, Watts   +4 more
openaire   +2 more sources

Psychedelics and schizophrenia

Trends in Neurosciences, 2009
Research on psychedelics such as lysergic acid diethylamide (LSD) and dissociative drugs such as phencyclidine (PCP) and the symptoms, neurochemical abnormalities and treatment of schizophrenia have converged. The effects of hallucinogenic drugs resemble some of the core symptoms of schizophrenia.
Javier, González-Maeso, Stuart C, Sealfon   +1 more
openaire   +2 more sources

Psychedelics as Transformative Therapeutics

American Journal of Psychiatry, 2023
Over the past decade, psychedelic compounds have emerged as potentially transformative therapeutics for a variety of intractable neuropsychiatric conditions. However, historically most of the basic science has utilized these compounds as probes to interrogate various endogenous neurotransmitter systems-mainly the serotonin 5-HT2A receptor.
Bryan L, Roth, Ryan H, Gumpper
openaire   +2 more sources

Psychedelic fungi

Current Biology
Several species of fungi, collectively known as 'psychedelic fungi', produce a range of psychoactive substances, such as psilocybin, ibotenic acid, muscimol and lysergic acid amides. These substances interact with neurotransmitter receptors in the human brain to induce profound psychological effects.
Jason, Slot, Dirk, Hoffmeister
openaire   +2 more sources